Delivery Order SPE2DB20D2014-SPE2DB25FA93X

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,547.48 firm fixed-price delivery order is for the supply of 4564352542 ! TETRACAINE 1% (20 MG/2 ML) VL 2ML, a pharmaceutical product. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,062.54 firm fixed-price delivery order is for the provision of 4,566,272,084 units of 0.5% tetracaine steri-unit solution in 4ml containers. The award has an ultimate completion date of October 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Tetracaine 0.5% Steri-Unit Solution, a pharmaceutical product, over the period ending on June 11, 2025. The contract has a firm fixed price of $4,886.54 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,711,705 units of Tetracaine 0.5% Steri-Unit Solution, 4 mL, to the U.S. government. The contract has a ceiling value of $1,491.48 and a completion date of May 28, 2024. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA)...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical sourcing and distribution services company. The order is for TETRACAINE 0.5% STERI-UNIT SOL 4ML, a specialty pharmaceutical product, with a potential value of $1,120.15 and a completion date of February 23, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,130.46 firm fixed-price delivery order is for the supply of TETRACAIN HCL 0.5% 12S, a medical product, to support military healthcare programs. The contract has an ultimate completion date of March 21, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award is for the delivery of Tetracaine 0.5% Steri-Unit Solution, 4 mL, to the Defense Logistics Agency (DLA), a defense agency. The contract has a total ceiling value of $7,124.96 and is a firm-fixed-price delivery order with a period of performance through June 30, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is not set aside for any specific business type. Amerisourcebergen...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tetracaine 0.5% Steri-Unit Solution 4 mL, a medical product. The Delivery Order has a Firm Fixed Price of $12,053.30 and a Period of Performance through May 17, 2023. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,152.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Tetracaine 0.5% Eye 1S, a pharmaceutical product, to support military treatment programs and facilities. The award is a firm fixed price delivery order under an Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tetracaine 0.5% Steri-Unit solution, a medical product used for anesthetic purposes. The contract has a ceiling value of $4,881.35 and is a firm fixed-price delivery order with a completion date of May 19, 2025. The contract is not set-aside and is an open competition....
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA93X
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,484.82 Firm Fixed Price Delivery Order is for the supply of TETRACAINE 0.5% STERI-UNIT SOL 4ML, a pharmaceutical product, with an ultimate completion date of February 3, 2025.

The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/2/25, 10:02 AM